World's Best Scientists 2026 revealed!
Cornelia Lass-Flörl

Cornelia Lass-Flörl

Award Badge
Microbiology
Austria
2026

D-Index & Metrics

Microbiology

D-Index
71
Citations
20082
World Ranking
1826
National Ranking
6

Research.com Recognitions

  • 2026 - Research.com Microbiology in Austria Leader Award
  • 2025 - Research.com Microbiology in Austria Leader Award

Overview

Cornelia Lass-Flörl is affiliated with Innsbruck Medical University in Austria and is recognized for extensive contributions to the field of medicine, with a particular focus on infectious diseases. Their academic output encompasses 383 publications primarily within medicine, including substantial work in infectious diseases, epidemiology, cell biology, molecular biology, and pulmonary and respiratory medicine.

Their research primarily addresses topics related to antifungal resistance and susceptibility, fungal infections and studies, plant pathogens and fungal diseases, nail diseases and treatments, SARS-CoV-2 and COVID-19 research, infectious diseases and mycology, as well as mycotoxins in agriculture and food.

Notable recent papers include:

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance (2020), published in The Lancet Infectious Diseases
  • Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion (2020), published in Intensive Care Medicine
  • COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment (2020), published in Journal of Fungi
  • The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin (2021), published in Drugs
  • Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium (2020), published in Antibiotics

Throughout their career, they have frequently collaborated with researchers including Martin Hoenigl, Oliver A. Cornely, Wilfried Posch, Amir Arastehfar, and Philipp Koehler.

Common publication venues for their work are:

  • Journal of Fungi
  • Journal of Antimicrobial Chemotherapy
  • Antimicrobial Agents and Chemotherapy
  • Clinical Microbiology and Infection
  • Mycoses

Best Publications

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

    O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino

  • ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

    O.A. Cornely;S. Arikan-Akdagli;E. Dannaoui;A.H. Groll

  • ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

    Frederic Tissot;Samir G. Agrawal;Livio Pagano;Georgios Petrikkos

  • Changing epidemiology of systemic fungal infections

    Malcolm Richardson;C Lass-Flörl

  • European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

    J Maertens;O Marchetti;R Herbrecht;O A Cornely

  • EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*

    Maiken C. Arendrup;Manuel Cuenca-Estrella;Cornelia Lass-Flörl;William Hope

  • The changing face of epidemiology of invasive fungal disease in Europe

    Cornelia Lass-Flörl

  • ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

    A.M. Tortorano;M. Richardson;E. Roilides;A. van Diepeningen

  • Antifungal drug resistance among Candida species: mechanisms and clinical impact

    Maurizio Sanguinetti;Brunella Posteraro;Cornelia Lass-Flörl

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012:diagnostic procedures

    M. Cuenca-Estrella;P. E Verweij;M. C Arendrup;S. Arikan-Akdagli

  • Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.

    J W M van der Linden;M C Arendrup;A Warris;Katrien Lagrou

  • ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

    A. Chowdhary;J. F. Meis;J. Guarro;G. S. de Hoog

  • Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience

    Cornelia Lass‐Flörl;Katharina Griff;Astrid Mayr;Andreas Petzer

  • In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

    C Lass-Flörl;G Kofler;G Kropshofer;J Hermans

  • Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry

    E. De Carolis;B. Posteraro;C. Lass-Flörl;A. Vella

  • The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients.

    Cornelia Lass-Flörl;Gudrun Resch;David Nachbaur;Astrid Mayr

  • Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain

    Klaus Leth Mortensen;Emilia Mellado;Cornelia Lass-Flörl;Juan Luis Rodriguez-Tudela

  • Zygomycosis in Solid Organ Transplant Recipients: A Prospective, Matched Case-Control Study to Assess Risks for Disease and Outcome

    Nina Singh;Jose M. Aguado;Hugo Bonatti;Graeme Forrest

  • Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

    A. Espinel-Ingroff;M. C. Arendrup;M. A. Pfaller;L. X. Bonfietti

  • Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

    A. Espinel-Ingroff;A.I. Aller;E. Canton;L.R. Castanon-Olivares

Frequent Co-Authors

Maiken Cavling Arendrup
Maiken Cavling Arendrup Statens Serum Institut
Manuel Cuenca-Estrella
Manuel Cuenca-Estrella Instituto de Salud Carlos III
Michaela Lackner
Michaela Lackner Innsbruck Medical University
Jacques F. Meis
Jacques F. Meis Canisius-Wilhelmina Ziekenhuis
Josep Guarro
Josep Guarro Rovira i Virgili University
William W. Hope
William W. Hope University of Liverpool
Oliver A. Cornely
Oliver A. Cornely University of Cologne
Paul E. Verweij
Paul E. Verweij Radboud University
Hanno Ulmer
Hanno Ulmer Innsbruck Medical University
Malcolm Richardson
Malcolm Richardson University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a range of related online degrees that complement this field. For those interested in healthcare, exploring online healthcare degrees can provide flexible, accredited options to advance your education without sacrificing your current commitments.

If you are considering public health as a complementary pathway, there are numerous programs designed for easier admission. Finding easy admission online MPH programs can be a strategic way to build skills in epidemiology or health policy, which align well with microbiology careers.

For those interested in a more specialized career, becoming a child life specialist is an option that blends healthcare knowledge with patient support. Understanding the child life specialist salary and job responsibilities can help guide your career decisions post-microbiology studies.

Additionally, individuals facing unique challenges can find hope through specific programs. There are numerous college degrees for felons that provide second chances, showing that higher education—especially online—can be accessible to a wide audience, including aspiring microbiologists with past records.

Best Scientists Citing Cornelia Lass-Flörl

Trending Scientists